STOCK TITAN

Kontrol Engages sagecomm to Market BioCloud

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Kontrol Energy Corp. (CSE:KNR, OTCQB:KNRLF) has engaged sagecomm, a marketing communications firm, to promote its Kontrol BioCloud technology. This real-time analyzer detects airborne viruses and is intended for various communal settings. CEO Paul Ghezzi stated that the timing is right to broaden the BioCloud narrative. Despite the positive sentiment, the company has not made claims about the product's efficacy against COVID-19. Kontrol has a history of growth, being recognized as one of Canada's fastest-growing firms in recent years.

Positive
  • Engagement of sagecomm for marketing efforts to expand BioCloud's reach.
  • BioCloud offers a potential solution for detecting airborne viruses in public spaces.
  • Recognition as one of Canada's fastest-growing companies in 2018 and 2019.
Negative
  • No claims made regarding the effectiveness of BioCloud against COVID-19.
  • Risks include reliance on unproven technology and lack of regulatory approvals.

- Kontrol BioCloud is a Safe Space Technology -

TORONTO, ON / ACCESSWIRE / September 4, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) ("Kontrol" or "Company") is pleased to announce that sagecomm, a leading marketing communications firm, has been engaged to share the BioCloud story across the country.

"Following the completion of several important development milestones we feel the time is appropriate to share our story and our technology development to a larger audience through the media," says Paul Ghezzi, CEO of Kontrol. "We look forward to working with the sagecomm team."

About sagecomm

sagecomm is a leading strategic marketing and communications firm whose principals have more than 20 years of progressive experience in marketing-communications in both public and private environments, including education, technology, healthcare, banking, non-profit, and government sectors.

"We are impressed with the Kontrol team and excited about the potential of BioCloud and look forward to creating a growing audience for Kontrol," added Jeff Sage, Co-Founder and Senior Strategist at sagecomm.

About Kontrol BioCloud

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy is one of Canada's fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean's.

2018 Startup 50 logo - orange

A close up of a signDescription automatically generated


Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.


For further information, contact:

Paul Ghezzi, Chief Executive Officer
paul@kontrolenergy.com or admin@kontrolenergy.com
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company's product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol's lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.



View source version on accesswire.com:
https://www.accesswire.com/604727/Kontrol-Engages-sagecomm-to-Market-BioCloud

FAQ

What is Kontrol Energy Corp doing to promote BioCloud?

Kontrol Energy has engaged sagecomm to market its BioCloud technology to a wider audience.

What is the purpose of the Kontrol BioCloud technology?

BioCloud is designed to detect airborne viruses in various spaces, including classrooms and hospitals.

What are the risks associated with the BioCloud technology?

Risks include potential ineffectiveness in detecting viruses and lack of regulatory approval.

What recognition has Kontrol Energy received?

Kontrol Energy was recognized as one of Canada's fastest-growing companies in 2018 and 2019.

KONTROL TECHNOLOGIES CORP

OTC:KNRLF

KNRLF Rankings

KNRLF Latest News

KNRLF Stock Data

7.42M
49.58M
11.96%
Information Technology Services
Technology
Link
United States of America
Vaughan